Mohammed Safi
Impact in
-
- Cancer Immunotherapy and Biomarkers
-
- Urinary Bladder and Prostate Research
Papers in
- Oncology 15
- Cancer Immunotherapy and Biomarkers 10
- Lung Cancer Research Studies 3
-
- Melanoma and MAPK Pathways 3
- Chromatin Remodeling and Cancer 3
- Co-authors
- Mahmoud Al‐Azab (6 shared papers)Mark Rowland (1 shared paper)C. W. M. Whitty (1 shared paper)Eveline Klinkenberg (1 shared paper)Toby Leslie (1 shared paper)Xiu Shan (3 shared papers)Abdullah Shopit (5 shared papers)Qiwei Chen (4 shared papers)
- Journals
- Medicine (3 papers)Frontiers in Oncology (3 papers)Frontiers in Immunology (2 papers)Cancer Medicine (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- ChinaYemenUnited States
In The Last Decade
Mohammed Safi
29 papers receiving 274 citations
Peers
Comparison fields: 5 of 69
- Oncology 105
- Urology 21
- Public Health, Environmental and Occupational Health 55
- Pharmacology 14
- Pulmonary and Respiratory Medicine 48
Countries citing papers authored by Mohammed Safi
This map shows the geographic impact of Mohammed Safi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed Safi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed Safi more than expected).
Fields of papers citing papers by Mohammed Safi
This network shows the impact of papers produced by Mohammed Safi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed Safi. The network helps show where Mohammed Safi may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohammed Safi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 49 | |
| 2 | 2020 | 40 | |
| 3 | 2022 | 17 | |
| 4 | 2022 | 16 | |
| 5 | 2023 | 16 | |
| 6 | 2024 | 14 | |
| 7 | 2021 | 12 | |
| 8 | 2021 | 11 | |
| 9 | 2022 | 10 | |
| 10 | 2025 | 10 | |
| 11 | 2004 | 9 | |
| 12 | 2022 | 8 | |
| 13 | 2023 | 8 | |
| 14 | 2022 | 7 | |
| 15 | 2021 | 6 | |
| 16 | 2022 | 5 | |
| 17 | 2021 | 5 | |
| 18 | 2023 | 5 | |
| 19 | 2022 | 5 | |
| 20 | 2022 | 4 |
About Mohammed Safi
Mohammed Safi is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Surgery and Epidemiology, having authored 31 papers that have together received 278 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Bladder and Urothelial Cancer Treatments (4 papers), Melanoma and MAPK Pathways (3 papers), Ferroptosis and cancer prognosis (3 papers), Urinary and Genital Oncology Studies (3 papers), Renal cell carcinoma treatment (3 papers), Lung Cancer Research Studies (3 papers) and Chromatin Remodeling and Cancer (3 papers). The work is most often cited by research in Oncology (105 citations), Urology (21 citations), Public Health, Environmental and Occupational Health (55 citations), Pharmacology (14 citations) and Pulmonary and Respiratory Medicine (48 citations). Mohammed Safi has collaborated with scholars based in China, Yemen and United States. Frequent co-authors include Mahmoud Al‐Azab, Mark Rowland, C. W. M. Whitty, Eveline Klinkenberg, Toby Leslie, Xiu Shan, Abdullah Shopit, Qiwei Chen, Elina Idiiatullina and Kamal Hezam. Their work appears in journals such as Medicine, Frontiers in Oncology, Frontiers in Immunology, Cancer Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.